IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA expected to approve third Covid vaccine dose for immunocompromised people


The FDA is expected to announce that immunocompromised people will be eligible for a third Covid-19 booster shot of both the Pfizer and Moderna vaccines. NBC News medical reporter Erika Edwards explains who would be eligible for a third dose and how approving a booster shot could conflict with guidance from the WHO.